Company / Free Cash Flow per Share
Protara Therapeutics, Inc. Free Cash Flow per Share History
FY2014-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.61
FY2016
5-year range
-$34.60 / -$0.41
FY2014-FY2016
Trend
-50.1%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-34.60 to $-0.61 over the past 2 years.
Based on SEC 10-K filings.
-0.61 in FY2016.
Improved from $-34.60 to $-0.61 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2016, free cash flow per share decreased 50.1% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.74 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2016 | -$0.61 | -50.1% |
| FY2015 | -$0.41 | +98.8% |
| FY2014 | -$34.60 | - |
As of FY2016 · SEC 10-K · Updated Jun 28, 2026